Shopping Cart 0
Cart Subtotal
AED 0

Asia-Pacific PDX Models Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 11744
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Asia-Pacific PDX models market is estimated to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for Asia-Pacific PDX models market are listed below:

Crown Bioscience Inc.

The Jackson Laboratory

Champion Oncology, Inc.

Charles River

Oncodesign

Wuxi AppTec

Horizon Discovery Group plc

Pharmatest Services

Hera Biolabs

EPO Berlin-Buch GmbH

Xentech

Urolead

Creative Animodel

EUROPDX

MI Bioresearch Inc

Aragen Bioscience

The market is further segmented into:

Type

Tumor Type

Application

End User

The Asia Pacific PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.

The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.

The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.

The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.

Based on geography, the market is segmented into:

Japan

China

India

South Korea

Australia

Singapore

Thailand

Malaysia

Indonesia

Philippines

Rest of Asia Pacific

Covered in this report

The report covers the present scenario and the growth prospects of the Asia-Pacific PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction 11

1.1 Objectives Of The Study 11

1.2 Market Definition 11

1.3 Overview Of Asia-Pacific Pdx Models Market 11

1.4 Currency And Pricing 12

1.5 Limitation 12

1.6 Markets Covered 12

2 Market Segmentation 14

2.1 Markets Covered 14

2.2 Geographic Scope 15

2.3 Years Considered For The Study 15

2.4 Currency And Pricing 16

2.5 Research Methodology 17

2.6 Primary Interviews With Key Opinion Leaders 20

2.7 Secondary Sources 21

2.8 Assumptions 21

3 Market Overview 22

3.1 Drivers 24

3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 24

3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 26

3.1.3 Rising Need For Personalized Medicine 27

3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 27

3.2 Restraints 28

3.2.1 High Cost Of Pdx Models 28

3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 28

3.3 Opprtunities 29

3.3.1 Increasing Demand For Humanized Pdx Models 29

3.4 Challenges 30

3.4.1 Limitations Of Pdx Models 30

4 Executive Summary 31

5 Premium Insights 33

6 Asia-Pacific Pdx Models Market, By Type 36

6.1 Overview 37

6.2 Mice Models 39

6.3 Rat Models 40

7 Asia-Pacific Pdx Models Market, By Tumor Type 41

7.1 Overview 42

7.2 Gastrointestinal Tumor Models 44

7.3 Gynecological Tumor Models 45

7.4 Respiratory Tumor Models 46

7.5 Urological Tumor Models 47

7.6 Hematological Tumor Models 48

7.7 Others 49

8 Asia-Pacific Pdx Models Market, By Application 50

8.1 Overview 51

8.2 Preclinical Drug Development And Oncology Research 53

8.3 Biomarker Analysis 54

9 Asia-Pacific Pdx Models Market, By End User 55

9.1 Overview 56

9.2 Contract Research Organizations 58

9.3 Pharmaceutical And Biotechnology Companies 59

9.4 Academic And Research Institutions 60

10 Asia-Pacific Pdx Models Market, By Geography 61

10.1 Asia Pacific 61

10.1.1 Japan 70

10.1.2 China 72

10.1.3 India 74

10.1.4 South Korea 76

10.1.5 Australia 78

10.1.6 Singapore 80

10.1.7 Thailand 82

10.1.8 Malaysia 84

10.1.9 Indonesia 87

10.1.10 Philippines 89

10.1.11 Rest Of Asia Pacific 91

11 Asia-Pacific Pdx Models Market, Company Landscape 92

11.1 Company Share Analysis: Asia Pacific 92

12 Company Profiles 93

12.1 Charles River 93

12.1.1 Company Overview 93

12.1.2 Revenue Analysis 93

12.1.3 Company Share Analysis 94

12.1.4 Product Portfolio 94

12.1.5 Recent Developments 94

12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 95

12.2.1 Company Overview 95

12.2.2 Geographic Presence 95

12.2.3 Company Share Analysis 96

12.2.4 Product Portfolio 96

12.2.5 Recent Developments 97

12.3 Champion Oncology, Inc 98

12.3.1 Company Overview 98

12.3.2 Revenue Analysis 98

12.3.3 Company Share Analysis 99

12.3.4 Product Portfolio 99

12.3.5 Recent Developments 99

12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 100

12.4.1 Company Overview 100

12.4.2 Product Portfolio 100

12.4.3 Recent Developments 100

12.5 Creative Animodel 101

12.5.1 Company Overview 101

12.5.2 Product Portfolio 101

12.5.3 Recent Developments 101

12.6 Epo Berlin-Buch Gmbh 102

12.6.1 Company Overview 102

12.6.2 Product Portfolio 102

12.6.3 Recent Developments 102

12.7 Europdx 103

12.7.1 Company Overview 103

12.7.2 Geographical Presence 103

12.7.3 Product Portfolio 104

12.7.4 Recent Developments 104

12.8 Hera Biolabs 105

12.8.1 Company Overview 105

12.8.2 Product Portfolio 105

12.8.3 Recent Developments 105

12.9 Horizon Discovery Group Plc 106

12.9.1 Company Overview 106

12.9.2 Revenue Analysis 106

12.9.3 Product Portfolio 107

12.9.4 Recent Developments 107

12.10 Mi Bioresearch Inc 108

12.10.1 Company Overview 108

12.10.2 Product Portfolio 108

12.10.3 Recent Developments 108

12.11 Oncodesign 109

12.11.1 Company Overview 109

12.11.2 Revenue Analysis 109

12.11.3 Product Portfolio 110

12.11.4 Recent Developments 110

12.12 Pharmatest Services Ltd 111

12.12.1 Company Overview 111

12.12.2 Geographic Presence 111

12.12.3 Product Portfolio 112

12.12.4 Recent Developments 112

12.13 The Jackson Laboratory 113

12.13.1 Company Overview 113

12.13.2 Revenue Analysis 113

12.13.3 Product Portfolio 114

12.13.4 Recent Developments 114

12.14 Urolead 115

12.14.1 Company Overview 115

12.14.2 Product Portfolio 115

12.14.3 Recent Developments 115

12.15 Wuxi Apptec 116

12.15.1 Company Overview 116

12.15.2 Geographic Presence 116

12.15.3 Product Portfolio 117

12.15.4 Recent Developments 117

12.16 Xentech 118

12.16.1 Company Overview 118

12.16.2 Product Portfolio 118

12.16.3 Recent Developments 118

13 Related Reports 119


List Of Figure

List Of Figures

Figure 1 Asia-Pacific Pdx Models Market: Segmentation 14

Figure 2 Asia-Pacific Pdx Models Market: Data Triangulation 17

Figure 3 Asia-Pacific Pdx Models Market: Research Snapshot 18

Figure 4 Asia-Pacific Pdx Models Market : Bottom Up Approach 19

Figure 5 Asia-Pacific Pdx Models Market : Top Down Approach 19

Figure 6 Asia-Pacific Pdx Models Market: Interview Demographics 20

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Pdx Models Market 23

Figure 8 Below Mentioned Is R&D Expense By The Jackson Laboratory For Year 2016-17: 25

Figure 9 Asia-Pacific Pdx Models Market: Segmentation 32

Figure 10 Rising Number Of Pharmaceutical R&D Activities In Cancer Research And Rising Need For Personalized Medicine Are Expected To Drive The Market For Pdx Models In The Forecast Period 2018 To 2025 33

Figure 11 Mice Models Is Expected To Account For The Largest Share Of The Asia-Pacific Pdx Models Market In 2018 & 2025 34

Figure 12 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Pdx Models Market In The Forecast Period From 2018 To 2025 35

Figure 13 Asia-Pacific Pdx Models Market: By Type, 2017 37

Figure 14 Asia-Pacific Pdx Models Market: By Tyumor Type, 2017 42

Figure 15 Asia-Pacific Pdx Models Market: By Application, 2017 51

Figure 16 Asia-Pacific Pdx Models Market: By End User, 2017 56

Figure 17 Asia Pacific Pdx Models Market Snapshot (2017) 61

Figure 18 Asia Pacific Pdx Models Market : By Country (2017) 63

Figure 19 Asia Pacific Pdx Models Market : By Country (2018 & 2025) 64

Figure 20 Asia Pacific Pdx Models Market: By Country (2017 & 2025) 65

Figure 21 Asia Pacific Pdx Models Market : By Type (2018-2025) 66

Figure 22 Asia-Pacific Pdx Models Market: Company Share 2017 (%) 92


List Of Table

List Of Tables

Uu

Table 1 Asia-Pacific Pdx Models Market, By Type, 2016- 2025, (Usd Million) 38

Table 2 Asia-Pacific Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 39

Table 3 Asia-Pacific Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 40

Table 4 Asia-Pacific Pdx Models Market, By Tumor Type, 2016- 2025 (Usd Million) 43

Table 5 Asia-Pacific Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million) 44

Table 6 Asia-Pacific Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million) 45

Table 7 Asia-Pacific Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million) 46

Table 8 Asia-Pacific Urological Tumor Models Market, By Region, 2016-2025, (Usd Million) 47

Table 9 Asia-Pacific Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million) 48

Table 10 Asia-Pacific Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million) 49

Table 11 Asia-Pacific Pdx Models Market, By Application, 2016- 2025 (Usd Million) 52

Table 12 Asia-Pacific Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million) 53

Table 13 Asia-Pacific Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million) 54

Table 14 Asia-Pacific Pdx Models Market, By End User, 2016- 2025, (Usd Million) 57

Table 15 Asia-Pacific Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million) 58

Table 16 Asia-Pacific Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million) 59

Table 17 Asia-Pacific Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million) 60

Table 18 Asia Pacific Pdx Models Market, By Country , 2016-2025, (Usd Million) 67

Table 19 Asia Pacific Pdx Models Market, By Type, 2016-2025, (Usd Million) 68

Table 20 Asia Pacific Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 68

Table 21 Asia Pacific Pdx Models Market, By Application, 2016-2025, (Usd Million) 69

Table 22 Asia Pacific Pdx Models Market, By End User, 2016-2025, (Usd Million) 69

Table 23 Japan Pdx Models Market, By Type, 2016-2025, (Usd Million) 70

Table 24 Japan Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 70

Table 25 Japan Pdx Models Market, By Application, 2016-2025, (Usd Million) 71

Table 26 Japan Pdx Models Market, By End User, 2016-2025, (Usd Million) 71

Table 27 China Pdx Models Market, By Type, 2016-2025, (Usd Million) 72

Table 28 China Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 72

Table 29 China Pdx Models Market, By Application, 2016-2025, (Usd Million) 73

Table 30 China Pdx Models Market, By End User, 2016-2025, (Usd Million) 73

Table 31 India Pdx Models Market, By Type, 2016-2025, (Usd Million) 74

Table 32 India Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 74

Table 33 India Pdx Models Market, By Application, 2016-2025, (Usd Million) 75

Table 34 India Pdx Models Market, By End User, 2016-2025, (Usd Million) 75

Table 35 South Korea Pdx Models Market, By Type, 2016-2025, (Usd Million) 76

Table 36 South Korea Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 76

Table 37 South Korea Pdx Models Market, By Application, 2016-2025, (Usd Million) 77

Table 38 South Korea Pdx Models Market, By End User, 2016-2025, (Usd Million) 77

Table 39 Australia Pdx Models Market, By Type, 2016-2025, (Usd Million) 78

Table 40 Australia Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 78

Table 41 Australia Pdx Models Market, By Application, 2016-2025, (Usd Million) 79

Table 42 Australia Pdx Models Market, By End User, 2016-2025, (Usd Million) 79

Table 43 Singapore Pdx Models Market, By Type, 2016-2025, (Usd Million) 80

Table 44 Singapore Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 80

Table 45 Singapore Pdx Models Market, By Application, 2016-2025, (Usd Million) 81

Table 46 Singapore Pdx Models Market, By End User, 2016-2025, (Usd Million) 81

Table 47 Thailand Pdx Models Market, By Type, 2016-2025, (Usd Million) 82

Table 48 Thailand Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 82

Table 49 Thailand Pdx Models Market, By Application, 2016-2025, (Usd Million) 83

Table 50 Thailand Pdx Models Market, By End User, 2016-2025, (Usd Million) 83

Table 51 Malaysia Pdx Models Market, By Type, 2016-2025, (Usd Million) 84

Table 52 Malaysia Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 85

Table 53 Malaysia Pdx Models Market, By Application, 2016-2025, (Usd Million) 85

Table 54 Malaysia Pdx Models Market, By End User, 2016-2025, (Usd Million) 86

Table 55 Indonesia Pdx Models Market, By Type, 2016-2025, (Usd Million) 87

Table 56 Indonesia Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 87

Table 57 Indonesia Pdx Models Market, By Application, 2016-2025, (Usd Million) 88

Table 58 Indonesia Pdx Models Market, By End User, 2016-2025, (Usd Million) 88

Table 59 Philippines Pdx Models Market, By Type, 2016-2025, (Usd Million) 89

Table 60 Philippines Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 89

Table 61 Philippines Pdx Models Market, By Application, 2016-2025, (Usd Million) 90

Table 62 Philippines Pdx Models Market, By End User, 2016-2025, (Usd Million) 90

Table 63 Rest Of Asia Pacific Pdx Models Market, By Type, 2016-2025, (Usd Million) 91

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Crown Bioscience Inc.

The Jackson Laboratory

Champion Oncology, Inc.

Charles River

Oncodesign

Wuxi AppTec

Horizon Discovery Group plc

Pharmatest Services

Hera Biolabs

EPO Berlin-Buch GmbH

Xentech

Urolead

Creative Animodel

EUROPDX

MI Bioresearch Inc

Aragen Bioscience

Asia-Pacific PDX models market is estimated to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for Asia-Pacific PDX models market are listed below:

Crown Bioscience Inc.

The Jackson Laboratory

Champion Oncology, Inc.

Charles River

Oncodesign

Wuxi AppTec

Horizon Discovery Group plc

Pharmatest Services

Hera Biolabs

EPO Berlin-Buch GmbH

Xentech

Urolead

Creative Animodel

EUROPDX

MI Bioresearch Inc

Aragen Bioscience

The market is further segmented into:

Type

Tumor Type

Application

End User

The Asia Pacific PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.

The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.

The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.

The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.

Based on geography, the market is segmented into:

Japan

China

India

South Korea

Australia

Singapore

Thailand

Malaysia

Indonesia

Philippines

Rest of Asia Pacific

Covered in this report

The report covers the present scenario and the growth prospects of the Asia-Pacific PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Scope

Table Of Contents

1 Introduction 11

1.1 Objectives Of The Study 11

1.2 Market Definition 11

1.3 Overview Of Asia-Pacific Pdx Models Market 11

1.4 Currency And Pricing 12

1.5 Limitation 12

1.6 Markets Covered 12

2 Market Segmentation 14

2.1 Markets Covered 14

2.2 Geographic Scope 15

2.3 Years Considered For The Study 15

2.4 Currency And Pricing 16

2.5 Research Methodology 17

2.6 Primary Interviews With Key Opinion Leaders 20

2.7 Secondary Sources 21

2.8 Assumptions 21

3 Market Overview 22

3.1 Drivers 24

3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 24

3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 26

3.1.3 Rising Need For Personalized Medicine 27

3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 27

3.2 Restraints 28

3.2.1 High Cost Of Pdx Models 28

3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 28

3.3 Opprtunities 29

3.3.1 Increasing Demand For Humanized Pdx Models 29

3.4 Challenges 30

3.4.1 Limitations Of Pdx Models 30

4 Executive Summary 31

5 Premium Insights 33

6 Asia-Pacific Pdx Models Market, By Type 36

6.1 Overview 37

6.2 Mice Models 39

6.3 Rat Models 40

7 Asia-Pacific Pdx Models Market, By Tumor Type 41

7.1 Overview 42

7.2 Gastrointestinal Tumor Models 44

7.3 Gynecological Tumor Models 45

7.4 Respiratory Tumor Models 46

7.5 Urological Tumor Models 47

7.6 Hematological Tumor Models 48

7.7 Others 49

8 Asia-Pacific Pdx Models Market, By Application 50

8.1 Overview 51

8.2 Preclinical Drug Development And Oncology Research 53

8.3 Biomarker Analysis 54

9 Asia-Pacific Pdx Models Market, By End User 55

9.1 Overview 56

9.2 Contract Research Organizations 58

9.3 Pharmaceutical And Biotechnology Companies 59

9.4 Academic And Research Institutions 60

10 Asia-Pacific Pdx Models Market, By Geography 61

10.1 Asia Pacific 61

10.1.1 Japan 70

10.1.2 China 72

10.1.3 India 74

10.1.4 South Korea 76

10.1.5 Australia 78

10.1.6 Singapore 80

10.1.7 Thailand 82

10.1.8 Malaysia 84

10.1.9 Indonesia 87

10.1.10 Philippines 89

10.1.11 Rest Of Asia Pacific 91

11 Asia-Pacific Pdx Models Market, Company Landscape 92

11.1 Company Share Analysis: Asia Pacific 92

12 Company Profiles 93

12.1 Charles River 93

12.1.1 Company Overview 93

12.1.2 Revenue Analysis 93

12.1.3 Company Share Analysis 94

12.1.4 Product Portfolio 94

12.1.5 Recent Developments 94

12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 95

12.2.1 Company Overview 95

12.2.2 Geographic Presence 95

12.2.3 Company Share Analysis 96

12.2.4 Product Portfolio 96

12.2.5 Recent Developments 97

12.3 Champion Oncology, Inc 98

12.3.1 Company Overview 98

12.3.2 Revenue Analysis 98

12.3.3 Company Share Analysis 99

12.3.4 Product Portfolio 99

12.3.5 Recent Developments 99

12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 100

12.4.1 Company Overview 100

12.4.2 Product Portfolio 100

12.4.3 Recent Developments 100

12.5 Creative Animodel 101

12.5.1 Company Overview 101

12.5.2 Product Portfolio 101

12.5.3 Recent Developments 101

12.6 Epo Berlin-Buch Gmbh 102

12.6.1 Company Overview 102

12.6.2 Product Portfolio 102

12.6.3 Recent Developments 102

12.7 Europdx 103

12.7.1 Company Overview 103

12.7.2 Geographical Presence 103

12.7.3 Product Portfolio 104

12.7.4 Recent Developments 104

12.8 Hera Biolabs 105

12.8.1 Company Overview 105

12.8.2 Product Portfolio 105

12.8.3 Recent Developments 105

12.9 Horizon Discovery Group Plc 106

12.9.1 Company Overview 106

12.9.2 Revenue Analysis 106

12.9.3 Product Portfolio 107

12.9.4 Recent Developments 107

12.10 Mi Bioresearch Inc 108

12.10.1 Company Overview 108

12.10.2 Product Portfolio 108

12.10.3 Recent Developments 108

12.11 Oncodesign 109

12.11.1 Company Overview 109

12.11.2 Revenue Analysis 109

12.11.3 Product Portfolio 110

12.11.4 Recent Developments 110

12.12 Pharmatest Services Ltd 111

12.12.1 Company Overview 111

12.12.2 Geographic Presence 111

12.12.3 Product Portfolio 112

12.12.4 Recent Developments 112

12.13 The Jackson Laboratory 113

12.13.1 Company Overview 113

12.13.2 Revenue Analysis 113

12.13.3 Product Portfolio 114

12.13.4 Recent Developments 114

12.14 Urolead 115

12.14.1 Company Overview 115

12.14.2 Product Portfolio 115

12.14.3 Recent Developments 115

12.15 Wuxi Apptec 116

12.15.1 Company Overview 116

12.15.2 Geographic Presence 116

12.15.3 Product Portfolio 117

12.15.4 Recent Developments 117

12.16 Xentech 118

12.16.1 Company Overview 118

12.16.2 Product Portfolio 118

12.16.3 Recent Developments 118

13 Related Reports 119


List Of Figure

List Of Figures

Figure 1 Asia-Pacific Pdx Models Market: Segmentation 14

Figure 2 Asia-Pacific Pdx Models Market: Data Triangulation 17

Figure 3 Asia-Pacific Pdx Models Market: Research Snapshot 18

Figure 4 Asia-Pacific Pdx Models Market : Bottom Up Approach 19

Figure 5 Asia-Pacific Pdx Models Market : Top Down Approach 19

Figure 6 Asia-Pacific Pdx Models Market: Interview Demographics 20

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Pdx Models Market 23

Figure 8 Below Mentioned Is R&D Expense By The Jackson Laboratory For Year 2016-17: 25

Figure 9 Asia-Pacific Pdx Models Market: Segmentation 32

Figure 10 Rising Number Of Pharmaceutical R&D Activities In Cancer Research And Rising Need For Personalized Medicine Are Expected To Drive The Market For Pdx Models In The Forecast Period 2018 To 2025 33

Figure 11 Mice Models Is Expected To Account For The Largest Share Of The Asia-Pacific Pdx Models Market In 2018 & 2025 34

Figure 12 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Pdx Models Market In The Forecast Period From 2018 To 2025 35

Figure 13 Asia-Pacific Pdx Models Market: By Type, 2017 37

Figure 14 Asia-Pacific Pdx Models Market: By Tyumor Type, 2017 42

Figure 15 Asia-Pacific Pdx Models Market: By Application, 2017 51

Figure 16 Asia-Pacific Pdx Models Market: By End User, 2017 56

Figure 17 Asia Pacific Pdx Models Market Snapshot (2017) 61

Figure 18 Asia Pacific Pdx Models Market : By Country (2017) 63

Figure 19 Asia Pacific Pdx Models Market : By Country (2018 & 2025) 64

Figure 20 Asia Pacific Pdx Models Market: By Country (2017 & 2025) 65

Figure 21 Asia Pacific Pdx Models Market : By Type (2018-2025) 66

Figure 22 Asia-Pacific Pdx Models Market: Company Share 2017 (%) 92


List Of Table

List Of Tables

Uu

Table 1 Asia-Pacific Pdx Models Market, By Type, 2016- 2025, (Usd Million) 38

Table 2 Asia-Pacific Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 39

Table 3 Asia-Pacific Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 40

Table 4 Asia-Pacific Pdx Models Market, By Tumor Type, 2016- 2025 (Usd Million) 43

Table 5 Asia-Pacific Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million) 44

Table 6 Asia-Pacific Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million) 45

Table 7 Asia-Pacific Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million) 46

Table 8 Asia-Pacific Urological Tumor Models Market, By Region, 2016-2025, (Usd Million) 47

Table 9 Asia-Pacific Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million) 48

Table 10 Asia-Pacific Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million) 49

Table 11 Asia-Pacific Pdx Models Market, By Application, 2016- 2025 (Usd Million) 52

Table 12 Asia-Pacific Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million) 53

Table 13 Asia-Pacific Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million) 54

Table 14 Asia-Pacific Pdx Models Market, By End User, 2016- 2025, (Usd Million) 57

Table 15 Asia-Pacific Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million) 58

Table 16 Asia-Pacific Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million) 59

Table 17 Asia-Pacific Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million) 60

Table 18 Asia Pacific Pdx Models Market, By Country , 2016-2025, (Usd Million) 67

Table 19 Asia Pacific Pdx Models Market, By Type, 2016-2025, (Usd Million) 68

Table 20 Asia Pacific Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 68

Table 21 Asia Pacific Pdx Models Market, By Application, 2016-2025, (Usd Million) 69

Table 22 Asia Pacific Pdx Models Market, By End User, 2016-2025, (Usd Million) 69

Table 23 Japan Pdx Models Market, By Type, 2016-2025, (Usd Million) 70

Table 24 Japan Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 70

Table 25 Japan Pdx Models Market, By Application, 2016-2025, (Usd Million) 71

Table 26 Japan Pdx Models Market, By End User, 2016-2025, (Usd Million) 71

Table 27 China Pdx Models Market, By Type, 2016-2025, (Usd Million) 72

Table 28 China Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 72

Table 29 China Pdx Models Market, By Application, 2016-2025, (Usd Million) 73

Table 30 China Pdx Models Market, By End User, 2016-2025, (Usd Million) 73

Table 31 India Pdx Models Market, By Type, 2016-2025, (Usd Million) 74

Table 32 India Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 74

Table 33 India Pdx Models Market, By Application, 2016-2025, (Usd Million) 75

Table 34 India Pdx Models Market, By End User, 2016-2025, (Usd Million) 75

Table 35 South Korea Pdx Models Market, By Type, 2016-2025, (Usd Million) 76

Table 36 South Korea Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 76

Table 37 South Korea Pdx Models Market, By Application, 2016-2025, (Usd Million) 77

Table 38 South Korea Pdx Models Market, By End User, 2016-2025, (Usd Million) 77

Table 39 Australia Pdx Models Market, By Type, 2016-2025, (Usd Million) 78

Table 40 Australia Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 78

Table 41 Australia Pdx Models Market, By Application, 2016-2025, (Usd Million) 79

Table 42 Australia Pdx Models Market, By End User, 2016-2025, (Usd Million) 79

Table 43 Singapore Pdx Models Market, By Type, 2016-2025, (Usd Million) 80

Table 44 Singapore Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 80

Table 45 Singapore Pdx Models Market, By Application, 2016-2025, (Usd Million) 81

Table 46 Singapore Pdx Models Market, By End User, 2016-2025, (Usd Million) 81

Table 47 Thailand Pdx Models Market, By Type, 2016-2025, (Usd Million) 82

Table 48 Thailand Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 82

Table 49 Thailand Pdx Models Market, By Application, 2016-2025, (Usd Million) 83

Table 50 Thailand Pdx Models Market, By End User, 2016-2025, (Usd Million) 83

Table 51 Malaysia Pdx Models Market, By Type, 2016-2025, (Usd Million) 84

Table 52 Malaysia Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 85

Table 53 Malaysia Pdx Models Market, By Application, 2016-2025, (Usd Million) 85

Table 54 Malaysia Pdx Models Market, By End User, 2016-2025, (Usd Million) 86

Table 55 Indonesia Pdx Models Market, By Type, 2016-2025, (Usd Million) 87

Table 56 Indonesia Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 87

Table 57 Indonesia Pdx Models Market, By Application, 2016-2025, (Usd Million) 88

Table 58 Indonesia Pdx Models Market, By End User, 2016-2025, (Usd Million) 88

Table 59 Philippines Pdx Models Market, By Type, 2016-2025, (Usd Million) 89

Table 60 Philippines Pdx Models Market, By Tumor Type, 2016-2025, (Usd Million) 89

Table 61 Philippines Pdx Models Market, By Application, 2016-2025, (Usd Million) 90

Table 62 Philippines Pdx Models Market, By End User, 2016-2025, (Usd Million) 90

Table 63 Rest Of Asia Pacific Pdx Models Market, By Type, 2016-2025, (Usd Million) 91

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Crown Bioscience Inc.

The Jackson Laboratory

Champion Oncology, Inc.

Charles River

Oncodesign

Wuxi AppTec

Horizon Discovery Group plc

Pharmatest Services

Hera Biolabs

EPO Berlin-Buch GmbH

Xentech

Urolead

Creative Animodel

EUROPDX

MI Bioresearch Inc

Aragen Bioscience